Fact based stock research
Baxter (NYSE:BAX)

US0718131099

Baxter stock research in summary

Baxter shares are more expensive than other comparable stocks. While they are safely financed, they show below average growth, and are poor value. We recommend evaluating whether the future of the company Baxter is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.

Latest Obermatt Ranks


Value Rank	27
Growth Rank	37
Safety Rank	71
Combined Rank	37

Country	USA
Industry	Health Care Equipment
Index	D.J. US Medical Equipment, S&P 500
Size class	X-Large

July 3, 2020. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

☀ Achievements

Top 10 Stock

Google: Baxter

News	Videos
Wikipedia about Baxter	Management
Employee Satisfaction	Customer Satisfaction

Research History: Baxter

RESEARCH HISTORY	2017	2018	2019	2020
VALUE
VALUE	33	33	30	27
GROWTH
GROWTH	60	28	51	37
SAFETY
SAFETY	78	79	49	71
COMBINED
COMBINED	65	51	34	37

Last update of Combined Rank: 3-Jul-2020. Financial reporting date used for calculating ranks: 31-Mar-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Baxter is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2017	2018	2019	2020
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	53	49	41	39
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	38	42	59	35
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	31	25	23	24
DIVIDEND YIELD
DIVIDEND YIELD	48	45	41	46
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	33	33	30	27

Last update of Value Rank: 3-Jul-2020. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Baxter; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2017	2018	2019	2020
REVENUE GROWTH
REVENUE GROWTH	30	30	20	30
PROFIT GROWTH
PROFIT GROWTH	24	21	65	53
STOCK RETURNS
STOCK RETURNS	87	64	53	53
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	60	28	51	37

Last update of Growth Rank: 31-Mar-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Baxter.

Safety Metrics in Detail

SAFETY METRICS	2017	2018	2019	2020
LEVERAGE
LEVERAGE	77	76	63	65
REFINANCING
REFINANCING	46	47	48	51
LIQUIDITY
LIQUIDITY	77	74	54	61
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	78	79	49	71

Last update of Safety Rank: 26-Jun-2020. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Baxter and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Baxter from July 3, 2020.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.